( March 5, 2025, 10:10 GMT | Official Statement) -- MLex Summary: An unjust enrichment lawsuit by two early Cornerstone Therapeutics investors would be better heard in China, a North Carolina Superior Court judge ruled. While Hengqin Dingsheng Zhirong Equity Investment Fund and Hengqin Dingsheng Zhilian Equity Investment Fund both pointed to the preparation in North Carolina of applications to patent an ischemic stroke treatment, that cannot overcome the reality that the lawsuit “was brought by plaintiffs based in China, centers around a Chinese company, and is governed by Chinese law,” Judge Mark A. Davis ruled.See attached document....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.